Trim AXP to 65-75% weight at $336; confirmed downtrend overrides fundamentals
Underweight rating reflects a 25-30% trim to 65-75% of target weight executed at current market ~$336, not a full exit. The confirmed downtrend (lower-high sequence, negative MACD expansion, price below all MAs) demands defensive tilt per the Aug 14 reflection, while the absence of fundamental deterioration (34.4% ROE, 16% EPS CAGR, widening moat) prevents the heavier 50-60% trim that the Aug 20 reflection falsified. Pure Hold at 100% weight is inadmissible given confirmed distribution; pure Sell forfeits the premium a closed-loop compounder with Berkshire's anchor warrants. Q3 2026 earnings is the defined validation catalyst.
| Position | Action |
|---|---|
| Confirmed downtrend with unanimous lower-high structure, negative MACD expansion, and price below all three MAs | Trim to 65-75% of target weight (25-30% reduction) |
AXP is a best-in-class compounding machine (34% ROE, 16% EPS CAGR) pulled back to its 200-day moving average on weak volume — offering an asymmetric entry point before the Gen Z pipeline and buyback mechanics drive per-share value higher.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 46.10 | neutral |
| MACD | -1.30 | bearish |
| MACD Signal | -0.32 | bearish |
| MACD Histogram | -0.98 | bearish |
| 10 EMA | 338.35 | bearish |
| 50 SMA | 342.03 | bearish |
| 200 SMA | 337.23 | neutral |
| Bollinger Middle (20 SMA) | 339.64 | bearish |
| Bollinger Upper Band | 349.13 | neutral |
| Bollinger Lower Band | 330.16 | bullish |
| ATR (14) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Successful $326 retest holding 2-3 sessions with declining volume and hammer/doji candle
Then: Re-engage toward target weight
Best-in-class fundamentals with accelerating growth
↩ rebuts: “Bear anchoring on lagging price action rather than underlying business quality”
EV: +7.1% (from $336 to $360 target) · concedes: Bear correctly identifies negative MACD and price below 10 EMA and 50 SMA; Bear correctly notes stock has lagged despite $98B in capital returns; Consumer credit risk from mass-market weakness is a legitimate concern, though AXP serves top 10-20% income quintile with 2-4 quarter lag; No immediate near-term relief catalyst acknowledged; catalysts include Q3 earnings (Oct), Gen Z traction data, and ongoing buyback support
AXP at $336 is not a "coiled spring" but a value-destructive entry: buybacks overpay at current prices, Gen Z adoption thesis has unaddressed demographic risks, macro credit deterioration has a 4-8 quarter lag, and the 16.7x forward PE is full, not cheap, for a financially cyclical company with intensifying competitive pressure.
EV: -$26 (8% decline from $338 entry to $312 midpoint of targets) · concedes: AXP is a great company with strong capital return history and brand moat; EPS growth from buybacks is technically true (shrinking share count); Confirmation-based entry requires waiting and potentially missing moves; March 2026 low of $291 did hold — supports some floor thesis
→ vs neutral: Wait-for-confirmation framework is already invalidated—the downtrend is confirmed, not potential: lower-high sequence complete, MACD negative, price below all MAs. Waiting longer means becoming a 'bag-holder in training'
→ vs conservative: Strong fundamentals at wrong price (16.7x P/E on 11% actual growth vs 21% implied) creates multiple compression trap; lagging stock narrative may mean market is correctly anticipating deterioration, not mispricing value
→ vs conservative: Berkshire not adding to AXP signal is 'relative-value warning shot'—marginal capital rotating to Alphabet and Delta, not into financials broadly
→ vs neutral: Lagging-stock-equals-value trap: AXP may be correctly pricing in pre-data deterioration; in macro, being early is same as being wrong on P&L
| 6.98 |
| neutral |
| VWMA | 340.68 | bearish |
| Close | 336.00 | neutral |
Support: 333.42 · 330.16 · 326.17 | Resistance: 338.35 · 339.64 · 342.03 · 349.13 · 361.57
AXP is in a short-term downtrend within a neutral long-term structure. Price (336.00) is trading near the lower Bollinger Band (330.16) with MACD bearish momentum still expanding (histogram at -0.98), indicating downside pressure rather than reversal. The 50 SMA (342.03) acts as key resistance while the 200 SMA (337.23) serves as a pivot point. RSI neutral at 46.10 leaves room for further downside before reaching oversold conditions. VWMA at 340.68 above price confirms bearish volume dynamics. The recommendation is HOLD with a bearish lean; traders should wait for either a reclaim of 339.64/342.03 with improving momentum or a decisive break below 330.16/326.17 with volume before taking action.
Market Cap
$226.9B
PE (TTM)
20.38x
Forward PE
16.71x
PEG Ratio
1.58
Price / Book
6.62x
Dividend Yield
1.15%
Profit Margin
16.14%
Operating Margin
20.32%
ROE
34.38%
ROA
3.79%
Revenue (2025)
$72.23B
Net Income (2025)
$10.83B
Diluted EPS (2025)
$15.38
Forward EPS
$20.11
Total Assets
$308.2B
Total Liabilities
$273.9B
Stockholders Equity
$34.28B
Book Value / Share
$50.79
Net Loans
$225.06B
Cash & Equivalents
$45.17B
Total Debt
$59.05B
Net Debt
$13.88B
Current Ratio
1.553
Debt-to-Equity
172x
Operating Cash Flow (2025)
$18.43B
Free Cash Flow (2025)
$16.00B
Capex (2025)
$2.43B
Dividends Paid (2025)
$2.27B
Buybacks (2025)
$5.81B
Total Capital Return (2025)
$8.08B
Revenue CAGR (2022-2025)
10.9%
Net Income CAGR (2022-2025)
13.0%
EPS CAGR (2022-2025)
16.0%
Equity CAGR (2022-2025)
11.0%
Q2 2026 Revenue
$19.637B
Q2 2026 Net Income
$3.110B
Q2 2026 Diluted EPS
$4.53
Q2 2026 Net Interest Income
$4.649B
Q2 2026 Operating Cash Flow
$5.371B
Q2 2026 FCF
$4.473B
Q2 2026 Buybacks
$2.30B
Diluted Shares (2025)
696M
Beta
1.055
52-Week High
$387.49
52-Week Low
$290.97
50-Day MA
$341.84
200-Day MA
$338.83
Strengths
Concerns
American Express demonstrates exceptional fundamentals with Q2 2026 EPS of $4.53 up 11% YoY on revenue of $19.637B, extending a streak of 5 consecutive quarters of revenue growth. The company generates best-in-class ROE of 34.4% and delivered 3-year EPS CAGR of 16.0% (2022–2025) through a combination of organic growth and aggressive share buybacks reducing share count by ~2.9% annually. While the valuation appears full at 16.7x forward PE with a PEG of 1.58, the diversified revenue model (discount, NII, fees) and robust $8.08B capital return program in 2025 provide meaningful downside protection against the primary risk of rate-driven NII compression.
Macro: Fed policy is on hold with near-zero probability of September cut (2%) and 12% probability of December cut. US recession odds priced at 8% (benign). 30-year Treasury yield remains above 5% with US federal debt crossed $40 trillion. ECB priced for 92% probability of 25bp September hike; Bank of England priced for 92% no change. Commodity tape showing oil, base metals rallying, gold breaking out—consistent with stagflationary drift. Iran geopolitical tensions easing modestly. Consumer spending bifurcated: Walmart signals lower-end caution while AXP's premium cardmember base (top 10–20% income) is more insulated but may lag lower-end stress by 2–4 quarters.